Mesanux 1200 Tablet is primarily used to manage ulcerative colitis, a chronic inflammatory condition characterised by inflammation and ulcers in the large intestine and rectum. This medicine belongs to the class of medications known as anti-inflammatory agents.
Mesanux 1200 Tablet is prescribed for:
• Managing mild to moderate ulcerative colitis
• Maintaining remission of ulcerative colitis
• Preventing flare-ups of ulcerative colitis
• Swallow the tablet whole with a glass of water.
• Do not crush, chew, or break the tablet, as this could affect its extended-release properties.
• Continue taking the medicine as directed by your doctor, and do not stop taking it without consulting your doctor first.
Mesanux 1200 Tablet is taken orally.
Common side effects of Mesanux 1200 Tablet may include:
• Nausea
• Vomiting
• Diarrhoea
• Abdominal pain
Mesanux 1200 Tablet contains mesalazine (1200 mg), which functions in the following manner:
• Inhibition of Inflammatory Mediators: Mesalazine works by inhibiting the production of inflammatory mediators such as prostaglandins and leukotrienes in the gut lining, thereby reducing inflammation in the bowel.
• Antioxidant Activity: Mesalazine also acts as an antioxidant, scavenging harmful free radicals that contribute to inflammation and tissue damage in the colon.
This medicine should be used only if potential benefit justifies the potential risk to fetus.
Caution is advised.
Avoid alcohol consumption as it can exacerbate ulcerative colitis symptoms.
Caution is advised.
Caution is advised.
Mesanux 1200 Tablet does not typically affect your ability to drive or operate machinery. However, consult your doctor if you experience dizziness.
Avoid if you have a known allergy to salicylates or any component of this medicine.
Not recommended for use in children under 18 years.
Older individuals may be more susceptible to side effects and should use Mesanux 1200 Tablet under medical supervision.
Drug-Drug Interactions
• non-steroidal anti-inflammatory drugs (NSAIDs): Concurrent use may increase the risk of kidney toxicity due to their combined renal effects.
• Thiopurines: Use with thiopurines may elevate the risk of myelosuppression, affecting blood cell production.
• Anticoagulants: Mesanux 1200 Tablet may reduce the anticoagulant effect of certain medications, potentially impacting their efficacy.
Drug-Disease Interactions
• Pyloric Stenosis: May delay the dissolution of the tablet, affecting mesalazine release and absorption in the intestines.
Daily Dosage
• Take Mesanux 1200 Tablet as instructed by your doctor, with the dosage tailored to your condition's severity and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor
Missed Dose
• If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take an extra dose without consulting your doctor.
Overdose
• Common symptoms of Mesanux 1200 Tablet overdose include nausea, vomiting, and abdominal pain. Seek medical attention if you suspect an overdose.
• Store Mesanux 1200 Tablet at room temperature, below 30°C.
• Keep the medicine in a dry place, protected from light and moisture.
• Ensure it is not exposed to excessive heat or cold.
• Keep out of reach of children.
• Use before the expiry date printed on the pack.
• Incorporate a high-fibre diet when managing ulcerative colitis with Mesanux 1200 Tablet, as it may help reduce colon inflammation. However, during flare-ups, fibre intake should be limited as it could exacerbate symptoms.
• Maintain hydration, especially if experiencing diarrhoea, by drinking plenty of fluids to prevent dehydration and potential kidney stones.
.avif)
%20(1).png)
.webp)